Sealink Impex Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth -48.18%
(FY 2023)
- Total Assets -49.22%
(FY 2023)
About Sealink Impex Pharma
The Corporate was formerly known as Esvee Technologies Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh, Sigatapu Vardhan, Ganesh Harry, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG2016PTC113769
- Company No.
113769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sealink Impex Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sigatapu Vardhan  | Director | 29-Dec-2016 | Current |
| Dinesh | Additional Director | 22-Feb-2019 | Current |
| Ganesh Harry | Additional Director | 22-Feb-2019 | Current |
| Trinath Tummepalli | Additional Director | 22-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Sealink Impex Pharma.
Sealink Impex Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sealink Impex Pharma?
In 2023, Sealink Impex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Intellidecs Infrastructure Private LimitedActive 13 years 5 monthsSigatapu Vardhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sealink Impex Pharma?
Unlock and access historical data on people associated with Sealink Impex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sealink Impex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sealink Impex Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
